| Year |
Citation |
Score |
| 2013 |
Ellinger JJ, Chylla RA, Ulrich EL, Markley JL. Databases and Software for NMR-Based Metabolomics. Current Metabolomics. 1. PMID 24260723 DOI: 10.2174/2213235X11301010028 |
0.417 |
|
| 2013 |
Clos LJ, Jofre MF, Ellinger JJ, Westler WM, Markley JL. NMRbot: Python scripts enable high-throughput data collection on current Bruker BioSpin NMR spectrometers. Metabolomics : Official Journal of the Metabolomic Society. 9: 558-563. PMID 23678341 DOI: 10.1007/S11306-012-0490-9 |
0.453 |
|
| 2012 |
Chae YK, Kim SH, Ellinger JJ, Markley JL. Tracing Metabolite Footsteps of Escherichia coli Along the Time Course of Recombinant Protein Expression by Two-Dimensional NMR Spectroscopy. Bulletin of the Korean Chemical Society. 33: 4041-4046. PMID 23794775 DOI: 10.5012/Bkcs.2012.33.12.4041 |
0.528 |
|
| 2012 |
Schwalbach MS, Keating DH, Tremaine M, Marner WD, Zhang Y, Bothfeld W, Higbee A, Grass JA, Cotten C, Reed JL, da Costa Sousa L, Jin M, Balan V, Ellinger J, Dale B, et al. Complex physiology and compound stress responses during fermentation of alkali-pretreated corn stover hydrolysate by an Escherichia coli ethanologen. Applied and Environmental Microbiology. 78: 3442-57. PMID 22389370 DOI: 10.1128/Aem.07329-11 |
0.303 |
|
| 2012 |
Ellinger JJ, Miller DC, Lewis IA, Markley JL. Semiautomated device for batch extraction of metabolites from tissue samples. Analytical Chemistry. 84: 1809-12. PMID 22292466 DOI: 10.1021/Ac203390V |
0.532 |
|
| 2011 |
Hu K, Ellinger JJ, Chylla RA, Markley JL. Measurement of absolute concentrations of individual compounds in metabolite mixtures by gradient-selective time-zero 1H-13C HSQC with two concentration references and fast maximum likelihood reconstruction analysis. Analytical Chemistry. 83: 9352-60. PMID 22029275 DOI: 10.1021/Ac201948F |
0.458 |
|
| 2011 |
Chylla RA, Hu K, Ellinger JJ, Markley JL. Deconvolution of two-dimensional NMR spectra by fast maximum likelihood reconstruction: application to quantitative metabolomics. Analytical Chemistry. 83: 4871-80. PMID 21526800 DOI: 10.1021/Ac200536B |
0.465 |
|
| 2011 |
Ellinger JJ, Lewis IA, Markley JL. Role of aminotransferases in glutamate metabolism of human erythrocytes. Journal of Biomolecular Nmr. 49: 221-9. PMID 21380856 DOI: 10.1007/S10858-011-9481-9 |
0.524 |
|
| 2011 |
Hallows WC, Yu W, Smith BC, Devries MK, Devires MK, Ellinger JJ, Someya S, Shortreed MR, Prolla T, Markley JL, Smith LM, Zhao S, Guan KL, Denu JM. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Molecular Cell. 41: 139-49. PMID 21255725 DOI: 10.1016/J.Molcel.2011.01.002 |
0.419 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Murdock L, Burke T, Coumoundouros C, Culham DE, Deutch CE, Ellinger J, Kerr CH, Plater SM, To E, Wright G, Wood JM. Analysis of strains lacking known osmolyte accumulation mechanisms reveals contributions of osmolytes and transporters to protection against abiotic stress. Applied and Environmental Microbiology. 80: 5366-78. PMID 24951793 DOI: 10.1128/Aem.01138-14 |
0.294 |
|
| 2017 |
Ellinger J, Schmidt-Dannert C. Construction of a BioBrick™ compatible vector system for Rhodococcus. Plasmid. PMID 28130036 DOI: 10.1016/J.Plasmid.2017.01.004 |
0.287 |
|
| 2014 |
Dietrich D, Meller S, Uhl B, Ralla B, Stephan C, Jung K, Ellinger J, Kristiansen G. Nucleic acid-based tissue biomarkers of urologic malignancies. Critical Reviews in Clinical Laboratory Sciences. 51: 173-99. PMID 24878394 DOI: 10.3109/10408363.2014.906130 |
0.135 |
|
| 1981 |
Cole MB, Ellinger J. Glycol methacrylate in light microscopy: Nucleic acid cytochemistry Journal of Microscopy. 123: 75-88. PMID 6167720 |
0.122 |
|
| 2012 |
Ellinger S, Gordon A, Kürten M, Jungfer E, Zimmermann BF, Zur B, Ellinger J, Marx F, Stehle P. Bolus consumption of a specifically designed fruit juice rich in anthocyanins and ascorbic acid did not influence markers of antioxidative defense in healthy humans. Journal of Agricultural and Food Chemistry. 60: 11292-300. PMID 23072538 DOI: 10.1021/jf300719t |
0.119 |
|
| 1994 |
Zenni GC, Ellinger J, Lam TM, Greisler HP. Biomaterial-induced macrophage activation and monokine release Journal of Investigative Surgery. 7: 135-141. PMID 8049176 DOI: 10.3109/08941939409015357 |
0.117 |
|
| 2015 |
Deng M, Blondeau JJ, Schmidt D, Perner S, Müller SC, Ellinger J. Identification of novel differentially expressed lncRNA and mRNA transcripts in clear cell renal cell carcinoma by expression profiling. Genomics Data. 5: 173-5. PMID 26484251 DOI: 10.1016/j.gdata.2015.06.016 |
0.1 |
|
| 1989 |
Greisler HP, Dennis JW, Endean ED, Ellinger J, Friesel R, Burgess W. Macrophage/biomaterial interactions: The stimulation of endothelialization Journal of Vascular Surgery. 9: 588-593. PMID 2523491 DOI: 10.1016/0741-5214(89)90478-3 |
0.099 |
|
| 2015 |
Latz S, Umbach T, Goltz D, Kristiansen G, Müller SC, Ellinger J. Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer. Urologia Internationalis. PMID 26287745 DOI: 10.1159/000438868 |
0.095 |
|
| 2009 |
Ellinger J, Albers P, Müller SC, Von Ruecker A, Bastian PJ. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker Bju International. 104: 48-52. PMID 19154496 DOI: 10.1111/J.1464-410X.2008.08289.X |
0.093 |
|
| 2014 |
Stein J, Majores M, Rohde M, Lim S, Schneider S, Krappe E, Ellinger J, Dietel M, Stephan C, Jung K, Perner S, Kristiansen G, Kirfel J. KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy. The American Journal of Pathology. 184: 2430-7. PMID 25016185 DOI: 10.1016/j.ajpath.2014.05.022 |
0.093 |
|
| 2015 |
Klümper N, Syring I, Offermann A, Shaikhibrahim Z, Vogel W, Müller SC, Ellinger J, Strauß A, Radzun HJ, Ströbel P, Brägelmann J, Perner S, Bremmer F. Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors. Diagnostic Pathology. 10: 165. PMID 26377566 DOI: 10.1186/s13000-015-0398-6 |
0.092 |
|
| 2009 |
Ellinger J, Wittkamp V, Albers P, Perabo FG, Mueller SC, von Ruecker A, Bastian PJ. Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. The Journal of Urology. 181: 363-71. PMID 19010497 DOI: 10.1016/J.Juro.2008.08.118 |
0.09 |
|
| 2012 |
Rogenhofer S, Kahl P, Mertens C, Hauser S, Hartmann W, Büttner R, Müller SC, von Ruecker A, Ellinger J. Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma. Bju International. 109: 459-65. PMID 21810159 DOI: 10.1111/j.1464-410X.2011.10278.x |
0.089 |
|
| 2015 |
Fischer N, Göke F, Kahl P, Splittstößer V, Lankat-Buttgereit B, Müller SC, Ellinger J. Programmed cell death protein 4 -expression in urologic tumors Open Pain Journal. 7: 7-11. DOI: 10.2174/1876822901407010007 |
0.088 |
|
| 1987 |
Greisler HP, Kim DU, Dennis JW, Klosak JJ, Widerborg KA, Endean ED, Raymond RM, Ellinger J. Compound polyglactin 910/polypropylene small vessel prostheses Journal of Vascular Surgery. 5: 572-583. PMID 3550160 DOI: 10.1016/0741-5214(87)90223-0 |
0.088 |
|
| 2015 |
Sakai Y, Abe K, Nakashima S, Ellinger JJ, Ferri S, Sode K, Ikebukuro K. Scaffold-fused riboregulators for enhanced gene activation in Synechocystis sp. PCC 6803. Microbiologyopen. PMID 25865486 DOI: 10.1002/mbo3.257 |
0.088 |
|
| 1976 |
Abraira C, Ellinger J. Modifications of metabolic adaptations to fasting by low dose oral glucose Clinical Research. 24: 355A. |
0.087 |
|
| 1988 |
Greisler HP, Endean ED, Klosak JJ, Ellinger J, Dennis JW, Buttle K, Un Kim D. Polyglactin 910/ polydioxanone bicomponent totally resorbable vascular prostheses Journal of Vascular Surgery. 7: 697-705. PMID 3130496 DOI: 10.1016/0741-5214(88)90016-X |
0.087 |
|
| 2008 |
Bastian PJ, Ellinger J, Von Rücker A, Müller SC, Yegnasubramanian S, Nelson WG, Stief CG. CpG island hypermethylation of the DNA: Perspectives of a molecular biomarker for prostate cancer | CpG-insel-hypermethylierung der DNA: Perspektiven eines molekularen biomarkers für das prostatakarzinom Urologe - Ausgabe A. 47: 1205-1207. PMID 18651120 DOI: 10.1007/S00120-008-1836-9 |
0.086 |
|
| 1986 |
Greisler HP, Schwarcz TH, Ellinger J, Kim DU. Dacron inhibition of arterial regenerative activities Journal of Vascular Surgery. 3: 747-756. PMID 3009903 DOI: 10.1016/0741-5214(86)90039-X |
0.086 |
|
| 2010 |
Stadler TC, Jung A, Schlenker B, Nuhn P, Ellinger J, Kirchner T, Stief CG, Bastian PJ. [Pyrosequencing in uro-oncology: applications in prostate cancer]. Der Urologe. Ausg. A. 49: 1356-64. PMID 20945059 DOI: 10.1007/s00120-010-2426-1 |
0.084 |
|
| 2015 |
Ellinger J, Müller SC, Dietrich D. Epigenetic biomarkers in the blood of patients with urological malignancies. Expert Review of Molecular Diagnostics. 15: 505-16. PMID 25719388 DOI: 10.1586/14737159.2015.1019477 |
0.083 |
|
| 2010 |
Ellinger J, Kahl P, Mertens C, Rogenhofer S, Hauser S, Hartmann W, Bastian PJ, Büttner R, Müller SC, von Ruecker A. Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma. International Journal of Cancer. Journal International Du Cancer. 127: 2360-6. PMID 20162570 DOI: 10.1002/ijc.25250 |
0.082 |
|
| 1987 |
Greisler HP, Klosak JJ, Dennis JW, Karesh SM, Ellinger J, Kim DU. Biomaterial pretreatment with ECGF to augment endothelial cell proliferation Journal of Vascular Surgery. 5: 393-402. PMID 2950245 DOI: 10.1016/0741-5214(87)90151-0 |
0.08 |
|
| 1991 |
Greisler HP, Ellinger J, Henderson SC, Shaheen AM, Burgess WH, Kim DU, Lam TM. The effects of an atherogenic diet on macrophage/biomaterial interactions. Journal of Vascular Surgery. 14: 10-23. PMID 1829487 DOI: 10.1016/0741-5214(91)90149-O |
0.078 |
|
| 2010 |
Ellinger J, von Rücker A, Bastian PJ, Müller SC. [Circulating cell-free serum DNA: significance as a new biomarker for urological malignancies]. Der Urologe. Ausg. A. 49: 1131-2, 1134. PMID 20628864 DOI: 10.1007/s00120-010-2342-4 |
0.078 |
|
| 2013 |
Hauser S, Zahalka T, Fechner G, Müller SC, Ellinger J. Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study. Anticancer Research. 33: 4651-6. PMID 24123044 |
0.077 |
|
| 2012 |
Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, et al. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gender Medicine. 9: 481-489. PMID 23217567 DOI: 10.1016/j.genm.2012.11.001 |
0.076 |
|
| 2012 |
Behbahani TE, Kahl P, von der Gathen J, Heukamp LC, Baumann C, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S, Ellinger J. Alterations of global histone H4K20 methylation during prostate carcinogenesis. Bmc Urology. 12: 5. PMID 22413846 DOI: 10.1186/1471-2490-12-5 |
0.076 |
|
| 2016 |
Ellinger J. Beyond Escherichia coli: Synthetic Biology-Focused Platforms and Toolboxes for Engineering other Bacteria Journal of Advanced Research in Biotechnology. 1: 1-4. DOI: 10.15226/2475-4714/1/2/00108 |
0.075 |
|
| 2012 |
Ellinger J, Kahl P, von der Gathen J, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S. Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer. Cancer Investigation. 30: 92-7. PMID 22149091 DOI: 10.3109/07357907.2011.636117 |
0.074 |
|
| 1987 |
Greisler HP, Ellinger J, Schwarcz TH, Golan J, Raymond RM, Kim D. Arterial Regeneration Over Polydioxanone Prostheses in the Rabbit Archives of Surgery. 122: 715-721. PMID 3107517 DOI: 10.1001/Archsurg.1987.01400180097019 |
0.074 |
|
| 2009 |
Ellinger J, Albers P, Perabo FG, Müller SC, von Ruecker A, Bastian PJ. CpG Island Hypermethylation of Cell-Free Circulating Serum DNA in Patients With Testicular Cancer Journal of Urology. 182: 324-329. PMID 19447423 DOI: 10.1016/j.juro.2009.02.106 |
0.073 |
|
| 1988 |
Greisler HP, Dennis JW, Endean ED, Ellinger J, Buttle KF, Kim DU. Derivation of neointima in vascular grafts Circulation. 78: I-6-I-12. PMID 2970347 |
0.072 |
|
| 2012 |
Rogenhofer S, Ellinger J, Kahl P, Stoehr C, Hartmann A, Engehausen D, Wieland WF, Müller SC, Hofstädter F, Walter B. Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer. Anticancer Research. 32: 3479-83. PMID 22843934 |
0.072 |
|
| 2012 |
Fischer N, Göke F, Splittstösser V, Lankat-Buttgereit B, Müller SC, Ellinger J. Expression of programmed cell death protein 4 (PDCD4) and miR-21 in urothelial carcinoma. Biochemical and Biophysical Research Communications. 417: 29-34. PMID 22133680 DOI: 10.1016/j.bbrc.2011.11.035 |
0.072 |
|
| 2003 |
Erzurum VZ, Bian JF, Husak VA, Ellinger J, Xue L, Burgess WH, Greisler HP. R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue. Journal of Vascular Surgery. 37: 1075-81. PMID 12756357 DOI: 10.1067/Mva.2003.177 |
0.072 |
|
| 2011 |
Ellinger J, Müller SC, Stadler TC, Jung A, von Ruecker A, Bastian PJ. The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer. Urologic Oncology. 29: 124-9. PMID 19762255 DOI: 10.1016/j.urolonc.2009.05.010 |
0.071 |
|
| 2014 |
Ellinger J, Bachmann A, Göke F, Behbahani TE, Baumann C, Heukamp LC, Rogenhofer S, Müller SC. Alterations of global histone H3K9 and H3K27 methylation levels in bladder cancer. Urologia Internationalis. 93: 113-8. PMID 24556868 DOI: 10.1159/000355467 |
0.071 |
|
| 2015 |
Blondeau JJ, Deng M, Syring I, Schrödter S, Schmidt D, Perner S, Müller SC, Ellinger J. Identification of novel long non-coding RNAs in clear cell renal cell carcinoma. Clinical Epigenetics. 7: 10. PMID 25685243 DOI: 10.1186/s13148-015-0047-7 |
0.07 |
|
| 2008 |
Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, Von Ruecker A, Bastian PJ. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer Prostate. 68: 42-49. PMID 18004747 DOI: 10.1002/pros.20651 |
0.07 |
|
| 2010 |
Pölcher M, Ellinger J, Willems S, El-Maarri O, Höller T, Amann C, Wolfgarten M, Rudlowski C, Kuhn W, Braun M. Impact of the menstrual cycle on circulating cell-free DNA. Anticancer Research. 30: 2235-40. PMID 20651374 |
0.07 |
|
| 2012 |
Hauser S, Kogej M, Fechner G, Von Ruecker A, Bastian PJ, Von Pezold J, Vorreuther R, Lümmen G, Müller SC, Ellinger J. Cell-free serum DNA in patients with bladder cancer: results of a prospective multicenter study. Anticancer Research. 32: 3119-24. PMID 22843882 |
0.069 |
|
| 1989 |
Greisler HP, Endean ED, Klosak JJ, Ellinger J, Henderson SC, Pham M, Durham SJ, Showalter DP, Levine J, Borovetz HS. Hemodynamic Effects on Endothelial Cell Monolayer Detachment From Vascular Prostheses Archives of Surgery. 124: 429-433. PMID 2930352 DOI: 10.1001/Archsurg.1989.01410040039008 |
0.069 |
|
| 2012 |
Scheid L, Ellinger S, Alteheld B, Herholz H, Ellinger J, Henn T, Helfrich HP, Stehle P. Kinetics of L-theanine uptake and metabolism in healthy participants are comparable after ingestion of L-theanine via capsules and green tea Journal of Nutrition. 142: 2091-2096. PMID 23096008 DOI: 10.3945/jn.112.166371 |
0.068 |
|
| 2010 |
Hauser S, Zahalka T, Ellinger J, Fechner G, Heukamp LC, VON Ruecker A, Müller SC, Bastian PJ. Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer. Anticancer Research. 30: 2785-9. PMID 20683013 |
0.067 |
|
| 2014 |
Latz S, Achterberg M, Ellinger J, Engels T, Hauser S, Rogenhofer S, Müller SC, Fechner G. Diagnostic meaning of urodynamic studies in pouch incontinence: results of a small series. Urologia Internationalis. 92: 237-41. PMID 24051578 DOI: 10.1159/000353417 |
0.067 |
|
| 2006 |
Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, Schüle R, Buettner R. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence Cancer Research. 66: 11341-11347. PMID 17145880 DOI: 10.1158/0008-5472.CAN-06-1570 |
0.067 |
|
| 2010 |
Mosashvilli D, Kahl P, Mertens C, Holzapfel S, Rogenhofer S, Hauser S, Büttner R, Von Ruecker A, Müller SC, Ellinger J. Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma. Cancer Science. 101: 2664-9. PMID 20825416 DOI: 10.1111/j.1349-7006.2010.01717.x |
0.066 |
|
| 2012 |
Sanders I, Holdenrieder S, Walgenbach-Brünagel G, von Ruecker A, Kristiansen G, Müller SC, Ellinger J. Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma International Journal of Urology. 19: 1017-1025. PMID 22788411 DOI: 10.1111/j.1442-2042.2012.03082.x |
0.066 |
|
| 2012 |
Göke F, Franzen A, Menon R, Goltz D, Kirsten R, Boehm D, Vogel W, Gok̈e A, Scheble V, Ellinger J, Gerigk U, Fend F, Wagner P, Schroeck A, Perner S. Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors Chest. 142: 1020-1026. PMID 22499828 DOI: 10.1378/chest.11-2943 |
0.065 |
|
| 2013 |
Schiffgen M, Schmidt DH, von Rücker A, Müller SC, Ellinger J. Epigenetic regulation of microRNA expression in renal cell carcinoma. Biochemical and Biophysical Research Communications. 436: 79-84. PMID 23707942 DOI: 10.1016/j.bbrc.2013.05.061 |
0.064 |
|
| 2012 |
Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, et al. External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 38: 637-42. PMID 22459902 DOI: 10.1016/j.ejso.2012.02.187 |
0.063 |
|
| 2016 |
Schrödter S, Braun M, Syring I, Klümper N, Deng M, Schmidt D, Perner S, Müller SC, Ellinger J. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma Molecular Cancer. 15. DOI: 10.1186/s12943-016-0495-5 |
0.063 |
|
| 1989 |
Greisler HP, Klosak JJ, Steinam S, Burgess WH, Henders on SC, Cabusao EA, Ellinger J. Platelet interactions with heparin binding growth factor and fibronectin Asaio Transactions. 35: 561-563. PMID 2597534 |
0.063 |
|
| 2015 |
Kohls K, Schmidt D, Holdenrieder S, Müller SC, Ellinger J. [Detection of cell-free lncRNA in serum of cancer patients]. Der Urologe. Ausg. A. 54: 819-25. PMID 25312755 DOI: 10.1007/s00120-014-3655-5 |
0.063 |
|
| 2008 |
Ellinger J, El Kassem N, Heukamp LC, Matthews S, Cubukluoz F, Kahl P, Perabo FG, Müller SC, von Ruecker A, Bastian PJ. Hypermethylation of Cell-Free Serum DNA Indicates Worse Outcome in Patients With Bladder Cancer Journal of Urology. 179: 346-352. PMID 18006010 DOI: 10.1016/j.juro.2007.08.091 |
0.062 |
|
| 2011 |
Hauptstock V, Kuriakose S, Schmidt D, Düster R, Müller SC, von Ruecker A, Ellinger J. Glutathione-S-transferase pi 1(GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide. Biochemical and Biophysical Research Communications. 412: 606-11. PMID 21855532 DOI: 10.1016/j.bbrc.2011.08.007 |
0.062 |
|
| 2013 |
Latz S, Müller SC, Ellinger J. Diagnostic und therapeutic value of cell-free circulating DNA as a non-invasive biomarker in patients with prostate cancer Current Cancer Therapy Reviews. 9: 258-264. DOI: 10.2174/157339470904140418094329 |
0.061 |
|
| 2011 |
Schneider AC, Heukamp LC, Rogenhofer S, Fechner G, Bastian PJ, von Ruecker A, Müller SC, Ellinger J. Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer. Bju International. 108: E290-6. PMID 21627749 DOI: 10.1111/j.1464-410X.2011.10203.x |
0.06 |
|
| 2012 |
Behbahani TE, Thierse C, Baumann C, Holl D, Bastian PJ, von Ruecker A, Müller SC, Ellinger J, Hauser S. Tyrosine kinase expression profile in clear cell renal cell carcinoma. World Journal of Urology. 30: 559-65. PMID 21969129 DOI: 10.1007/s00345-011-0767-z |
0.06 |
|
| 1993 |
Greisler HP, Petsikas D, Lam TM, Patel N, Ellinger J, Cabusao E, Tattersall CW, Kim DU. Kinetics of cell proliferation as a function of vascular graft material Journal of Biomedical Materials Research. 27: 955-961. PMID 8360222 DOI: 10.1002/Jbm.820270715 |
0.06 |
|
| 2013 |
May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, et al. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a Urologic Oncology: Seminars and Original Investigations. 31: 1141-1147. PMID 22056404 DOI: 10.1016/j.urolonc.2011.09.011 |
0.059 |
|
| 2012 |
Rogenhofer S, Kahl P, Holzapfel S, VON Ruecker A, Mueller SC, Ellinger J. Decreased levels of histone H3K9me1 indicate poor prognosis in patients with renal cell carcinoma. Anticancer Research. 32: 879-86. PMID 22399607 |
0.059 |
|
| 2013 |
Rogenhofer S, Miersch H, Göke F, Kahl P, Wieland WF, Hofstädter F, Kristiansen G, von Ruecker A, Müller SC, Ellinger J. Histone methylation defines an epigenetic entity in penile squamous cell carcinoma. The Journal of Urology. 189: 1117-22. PMID 22999995 DOI: 10.1016/j.juro.2012.08.221 |
0.059 |
|
| 2005 |
Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, Von Ruecker A. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci Clinical Cancer Research. 11: 4097-4106. PMID 15930345 DOI: 10.1158/1078-0432.CCR-04-1832 |
0.058 |
|
| 2006 |
Brewster L, Brey EM, Addis M, Xue L, Husak V, Ellinger J, Haudenschild CC, Greisler HP. Improving endothelial healing with novel chimeric mitogens. American Journal of Surgery. 192: 589-93. PMID 17071189 DOI: 10.1016/J.Amjsurg.2006.08.005 |
0.056 |
|
| 2008 |
Koch LK, Zhou H, Ellinger J, Biermann K, Höller T, von Rücker A, Büttner R, Gütgemann I. Stem cell marker expression in small cell lung carcinoma and developing lung tissue Human Pathology. 39: 1597-1605. PMID 18656241 DOI: 10.1016/j.humpath.2008.03.008 |
0.055 |
|
| 2010 |
Ellinger J, Kahl P, Von Der Gathen J, Rogenhofer S, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Büttner R, Müller SC, Bastian PJ, Von Ruecker A. Global levels of histone modifications predict prostate cancer recurrence Prostate. 70: 61-69. PMID 19739128 DOI: 10.1002/pros.21038 |
0.054 |
|
| 1990 |
Greisler HP, Klosak JJ, McGurrin JF, Endean ED, Ellinger J, Pozar JD, Henderson SC, Kim DU. Prostacyclin production by blood-contacting surfaces of endothelialized vascular prostheses Journal of Cardiovascular Surgery. 31: 640-645. PMID 2146273 |
0.051 |
|
| 2011 |
May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, et al. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder. Scandinavian Journal of Urology and Nephrology. 45: 251-7. PMID 21388337 DOI: 10.3109/00365599.2011.562235 |
0.051 |
|
| 2014 |
Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Müller SC, Ellinger J. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World Journal of Urology. 32: 353-8. PMID 23266581 DOI: 10.1007/s00345-012-1010-2 |
0.051 |
|
| 2008 |
Ellinger J, Von Rücker A, Wernert N, Büttner R, Bastian PJ, Müller SC. Prostate cancer research: Biomarkers as promising options for optimized diagnosis and treatment | Prostatakarzinomforschung: Biomarker als hoffnung für optimierte diagnostik und therapie Urologe - Ausgabe A. 47: 1190-1192. PMID 18651121 DOI: 10.1007/s00120-008-1833-z |
0.051 |
|
| 2012 |
May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, et al. External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder. The Journal of Urology. 187: 1210-4. PMID 22335861 DOI: 10.1016/j.juro.2011.11.104 |
0.05 |
|
| 2015 |
Schmid M, Rink M, Traumann M, Bastian PJ, Bartsch G, Ellinger J, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Aziz A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, et al. Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? Annals of Surgical Oncology. 22: 1032-42. PMID 25164037 DOI: 10.1245/s10434-014-4029-3 |
0.05 |
|
| 2014 |
Weiss VL, Braun M, Perner S, Harz A, Vorreuther R, Kristiansen G, Müller SC, Ellinger J. Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC). Bju International. 113: 209-17. PMID 24053185 DOI: 10.1111/bju.12322 |
0.049 |
|
| 2008 |
Ellinger J, Bastian PJ, Haan KI, Heukamp LC, Buettner R, Fimmers R, Mueller SC, von Ruecker A. Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators. International Journal of Cancer. Journal International Du Cancer. 122: 138-43. PMID 17764114 DOI: 10.1002/ijc.23057 |
0.049 |
|
| 2008 |
Ellinger J, Müller SC, Wernert N, Von Ruecker A, Bastian PJ. Mitochondrial DNA in serum of patients with prostate cancer: A predictor of biochemical recurrence after prostatectomy Bju International. 102: 628-632. PMID 18410441 DOI: 10.1111/j.1464-410X.2008.07613.x |
0.049 |
|
| 2011 |
May M, Fritsche HM, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, et al. [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder]. Der Urologe. Ausg. A. 50: 821-9. PMID 21340593 DOI: 10.1007/s00120-011-2507-9 |
0.048 |
|
| 2014 |
Westermann AM, Schmidt D, Holdenrieder S, Moritz R, Semjonow A, Schmidt M, Kristiansen G, Müller SC, Ellinger J. Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study. Anticancer Research. 34: 665-9. PMID 24510997 |
0.048 |
|
| 2006 |
Ellinger S, Ellinger J, Stehle P. Tomatoes, tomato products and lycopene in the prevention and treatment of prostate cancer: Do we have the evidence from intervention studies? Current Opinion in Clinical Nutrition and Metabolic Care. 9: 722-727. PMID 17053426 DOI: 10.1097/01.mco.0000247470.64532.34 |
0.048 |
|
| 2012 |
Shaikhibrahim Z, Lindstrot A, Ellinger J, Rogenhofer S, Buettner R, Wernert N. Genes differentially expressed in the peripheral zone compared to the transitional zone of the normal human prostate and their potential regulation by ETS factors Molecular Medicine Reports. 5: 32-36. PMID 21993862 DOI: 10.3892/mmr.2011.628 |
0.048 |
|
| 1987 |
Schwarcz TH, Nussbaum ML, Ellinger J, Kim DU, Greisler HP. Prostaglandin content of tissue lining vascular prostheses Current Surgery. 44: 18-21. PMID 3829709 |
0.048 |
|
| 2013 |
Hauser S, Kogej M, Fechner G, VON Pezold J, Vorreuther R, Lümmen G, Müller SC, Ellinger J. Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study. Anticancer Research. 33: 779-84. PMID 23482744 |
0.046 |
|
| 2007 |
Ellinger S, Ellinger J, Stehle P. Tomatoes, tomato products and lycopene in prevention and therapy of carcinoma of the prostate - What has been verified? | Tomaten, Tomatenprodukte und Lykopin in der Prävention und Therapie des Prostatakarzinoms - Was ist Gesichert? Ernahrungs Umschau. 54: 318-323+307. |
0.046 |
|
| 2013 |
Du J, Bittner F, Hecht DS, Ladous C, Ellinger J, Oekermann T, Wark M. A carbon nanotube-based transparent conductive substrate for flexible ZnO dye-sensitized solar cells Thin Solid Films. 531: 391-397. DOI: 10.1016/J.Tsf.2012.12.051 |
0.046 |
|
| 2012 |
Ellinger J, Müller DC, Müller SC, Hauser S, Heukamp LC, von Ruecker A, Bastian PJ, Walgenbach-Brunagel G. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies. Urologic Oncology. 30: 509-15. PMID 20870429 DOI: 10.1016/j.urolonc.2010.03.004 |
0.045 |
|
| 2011 |
Ellinger J, Holl D, Nuhn P, Kahl P, Haseke N, Staehler M, Siegert S, Hauser S, Stief CG, Müller SC, Bastian PJ. DNA hypermethylation in papillary renal cell carcinoma. Bju International. 107: 664-9. PMID 20553257 DOI: 10.1111/j.1464-410X.2010.09468.x |
0.044 |
|
| 2008 |
Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC, von Ruecker A. CpG Island Hypermethylation at Multiple Gene Sites in Diagnosis and Prognosis of Prostate Cancer Urology. 71: 161-167. PMID 18242387 DOI: 10.1016/j.urology.2007.09.056 |
0.044 |
|
| 2013 |
Moritz R, Ellinger J, Nuhn P, Haese A, Müller SC, Graefen M, Schlomm T, Bastian PJ. DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer Anticancer Research. 33: 5249-5254. |
0.044 |
|
| 2007 |
Ellinger J, Bastian PJ, Biermann K, Schmidt ME, Textor J, Bollmann D, Zhou H, Müller SC. Prostate cancer tissue is masked by bicalutamide: A case report European Journal of Medical Research. 12: 212-215. PMID 17513193 |
0.044 |
|
| 2009 |
Kahl P, Wolf S, Adam A, Heukamp LC, Ellinger J, Vorreuther R, Solleder G, Buettner R. Saturation biopsy improves preoperative Gleason scoring of prostate cancer Pathology Research and Practice. 205: 259-264. PMID 19106019 DOI: 10.1016/j.prp.2008.10.010 |
0.044 |
|
| 2011 |
Shaikhibrahim Z, Lindstrot A, Ellinger J, Rogenhofer S, Buetner R, Wernert N. Identification of immunity-related genes in prostate cancer and potential role of the ETS family of transcription factors in their regulation International Journal of Molecular Medicine. 28: 799-807. PMID 21833467 DOI: 10.3892/ijmm.2011.771 |
0.044 |
|
| 2010 |
Magerl C, Ellinger J, Braunschweig T, Kremmer E, Koch LK, Höller T, Büttner R, Lüscher B, Gütgemann I. H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1 Human Pathology. 41: 181-189. PMID 19896696 DOI: 10.1016/j.humpath.2009.08.007 |
0.043 |
|
| 2015 |
Aziz A, Gierth M, Rink M, Schmid M, Chun FK, Dahlem R, Roghmann F, Palisaar RJ, Noldus J, Ellinger J, Müller SC, Pycha A, Martini T, Bolenz C, Moritz R, et al. Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta. World Journal of Urology. PMID 25947885 DOI: 10.1007/s00345-015-1572-x |
0.043 |
|
| 2015 |
Li D, Ellinger J, Liu Z, Wu Z, Zhang Z. Mixed signal detection and symbol rate estimation based on spectral coherent features Proceedings - Ieee Military Communications Conference Milcom. 2015: 263-268. DOI: 10.1109/MILCOM.2015.7357453 |
0.042 |
|
| 2011 |
Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC, Ellinger J. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. Plos One. 6: e25787. PMID 21984948 DOI: 10.1371/journal.pone.0025787 |
0.041 |
|
| 2012 |
Behbahani TE, Ellinger J, Caratozzolo DG, Müller SC. Pathological outcomes of men eligible for active surveillance after undergoing radical prostatectomy: are results predictable? Clinical Genitourinary Cancer. 10: 32-6. PMID 22104434 DOI: 10.1016/j.clgc.2011.09.004 |
0.04 |
|
| 2013 |
Ellinger J, Wu Z. Cost function analysis for FD-MC-CDMA blind frequency offset estimation in high speed aerial communication Proceedings - Ieee Military Communications Conference Milcom. 797-802. DOI: 10.1109/MILCOM.2013.141 |
0.039 |
|
| 2004 |
Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: Is there a correlation with clinical stage, gleason grade, PSA value or age? European Journal of Medical Research. 9: 523-527. PMID 15649863 |
0.039 |
|
| 2013 |
Latz S, Ellinger J, Goltz D, Marx C, Leuschner I, Müller SC, Fechner G. Spindle cell rhabdomyosarcoma of the prostate. International Journal of Urology : Official Journal of the Japanese Urological Association. 20: 935-7. PMID 23320845 DOI: 10.1111/iju.12082 |
0.039 |
|
| 1990 |
Greisler HP, McGurrin JF, Klosak JJ, Tattersall CW, Ellinger J, Henderson SC, Cabusao EA. The validity of canine platelet aggregometry in predicting vascular graft patency Journal of Cardiovascular Surgery. 31: 712-718. PMID 2262494 |
0.039 |
|
| 1989 |
Greisler HP, Dennis JW, Schwarcz TH, Klosak JJ, Ellinger J, Kim D. Plasma Polymerized Tetrafluoroethylene/Polyethylene Terephthalate Vascular Prostheses Archives of Surgery. 124: 967-972. PMID 2527022 DOI: 10.1001/Archsurg.1989.01410080103017 |
0.038 |
|
| 2007 |
Strunk T, Bastian PJ, Ellinger J, Biermann K, Müller SC. Aggressive course of a malignant alveolar soft tissue sarcoma | Aggressive verlaufsform eines malignen alveolären weichteilsarkoms Urologe - Ausgabe A. 46: 1422-1424. PMID 17641862 DOI: 10.1007/s00120-007-1509-0 |
0.037 |
|
| 2007 |
Bastian PJ, Ellinger J, Müller SC, Von Rücker A. Epigenetics of prostate cancer | Epigenetik des prostatakarzinoms: Untersuchung zellulärer informationsträger jenseits der DNA-sequenz Urologe - Ausgabe A. 46: 1080-1081. PMID 17619844 DOI: 10.1007/s00120-007-1433-3 |
0.036 |
|
| 2010 |
May M, Fritsche HM, Brookman-May S, Burger M, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, et al. [Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens]. Der Urologe. Ausg. A. 49: 1508-15. PMID 20922515 DOI: 10.1007/s00120-010-2424-3 |
0.036 |
|
| 2011 |
May M, Burger M, Brookman-May S, Otto W, Peter J, Rud O, Fritsche HM, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Moritz R, Tiemann A, Müller SC, ... Ellinger J, et al. [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?]. Der Urologe. Ausg. A. 50: 706-13. PMID 21340594 DOI: 10.1007/s00120-011-2506-x |
0.036 |
|
| 2012 |
Oll M, Baumann C, Behbahani TE, von Ruecker A, Müller SC, Ellinger J. Identification of prostaglandin receptors in human ureters. Bmc Urology. 12: 35. PMID 23227994 DOI: 10.1186/1471-2490-12-35 |
0.036 |
|
| 1986 |
Greisler HP, Klosak J, Dennis JW, Ellinger J, Un Kim D, Burgess W, Maciag T. Endothelial cell growth factor attachment to biomaterials. Asaio Transactions / American Society For Artificial Internal Organs. 32: 346-9. PMID 3535846 |
0.035 |
|
| 2008 |
Perabo FGE, Von Löw EC, Ellinger J, von Rücker A, Müller SC, Bastian PJ. Soy isoflavone genistein in prevention and treatment of prostate cancer Prostate Cancer and Prostatic Diseases. 11: 6-12. PMID 17923857 DOI: 10.1038/sj.pcan.4501000 |
0.034 |
|
| 2008 |
Ellinger J, Bastian PJ, Ellinger N, Kahl P, Perabo FG, Büttner R, Müller SC, Ruecker Av. Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity Cancer Letters. 264: 274-280. PMID 18329789 DOI: 10.1016/j.canlet.2008.01.038 |
0.034 |
|
| 2014 |
Ellinger J, Muller SC. MicroRNAs: a novel non-invasive biomarker for patients with urological malignancies. Current Pharmaceutical Biotechnology. 15: 486-91. PMID 24846060 |
0.034 |
|
| 2011 |
Mahn R, Heukamp LC, Rogenhofer S, von Ruecker A, Müller SC, Ellinger J. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology. 77: 1265.e9-16. PMID 21539977 DOI: 10.1016/j.urology.2011.01.020 |
0.033 |
|
| 2009 |
Ellinger S, Ellinger J, Müller SC, Stehle P. Tomatoes and lycopene in prevention and therapy - Is there an evidence for prostate diseases? | Tomaten und Lykopin in Prävention und Therapie - Gibt es Eine Evidenz bei Prostataerkrankungen? Aktuelle Urologie. 40: 37-43. PMID 19177320 DOI: 10.1055/s-2008-1077031 |
0.033 |
|
| 2007 |
Bastian PJ, Ellinger J, Heukamp LC, Kahl P, Müller SC, von Rücker A. Prognostic Value of CpG Island Hypermethylation at PTGS2, RAR-beta, EDNRB, and Other Gene Loci in Patients Undergoing Radical Prostatectomy European Urology. 51: 665-674. PMID 16956712 DOI: 10.1016/j.eururo.2006.08.008 |
0.033 |
|
| 2004 |
Laredo J, Xue L, Husak VA, Ellinger J, Singh G, Zamora PO, Greisler HP. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. Journal of Vascular Surgery. 39: 1059-65. PMID 15111862 DOI: 10.1016/J.Jvs.2003.12.025 |
0.032 |
|
| 1966 |
Vaught GM, Ellinger J. Field-dependence and form discrimination Psychonomic Science. 6: 357-358. DOI: 10.3758/BF03330935 |
0.032 |
|
| 2014 |
Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, et al. Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: An external validation World Journal of Urology. 32: 365-371. PMID 23736527 DOI: 10.1007/s00345-013-1105-4 |
0.032 |
|
| 2008 |
Fischer N, Bastian PJ, Ellinger J, Simon A, Bode U, Biermann K, Hadizadeh D, Müller SC. Pediatric renal cell carcinoma. A rare differential diagnosis of Wilms' tumor | Das nierenzellkarzinom beim kind. Eine seltene differenzialdiagnose zum Wilms-tumor Urologe - Ausgabe A. 47: 620-623. PMID 18210066 DOI: 10.1007/s00120-007-1620-2 |
0.031 |
|
| 1986 |
Schwarcz TH, Nussbaum ML, Ellinger J, Greisler HP. Inner capsule prostaglandin content of vascular prostheses Surgical Forum. 37: 441-442. |
0.031 |
|
| 2011 |
May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, et al. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Annals of Surgical Oncology. 18: 2018-25. PMID 21246405 DOI: 10.1245/s10434-010-1538-6 |
0.03 |
|
| 2009 |
Perabo FGE, Von Löw EC, Siener R, Ellinger J, Müller SC, Bastian PJ. A critical assessment of phytotherapy for prostate cancer | Eine kritische bewertung der phytotherapie des prostatakarzinoms Urologe - Ausgabe A. 48: 270-283. PMID 19153707 DOI: 10.1007/s00120-008-1929-5 |
0.03 |
|
| 2008 |
Brumovsky M, Brynda J, Ellinger J. Welding repair procedure of defects in WWER reactor pressure vessels American Society of Mechanical Engineers, Pressure Vessels and Piping Division (Publication) Pvp. 6: 907-911. DOI: 10.1115/PVP2007-26324 |
0.029 |
|
| 2003 |
Laredo J, Xue L, Husak VA, Ellinger J, Greisler HP. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. American Journal of Surgery. 186: 556-60. PMID 14599625 DOI: 10.1016/J.Amjsurg.2003.07.015 |
0.028 |
|
| 1995 |
Gosselin C, Ren D, Ellinger J, Greisler HP. In vivo platelet deposition on polytetrafluoroethylene coated with fibrin glue containing fibroblast growth factor 1 and heparin in a canine model The American Journal of Surgery. 170: 126-130. PMID 7543261 DOI: 10.1016/S0002-9610(99)80270-0 |
0.028 |
|
| 2011 |
May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, et al. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. European Urology. 59: 712-8. PMID 21296488 DOI: 10.1016/j.eururo.2011.01.030 |
0.028 |
|
| 2012 |
Hauser S, Rogenhofer S, Ellinger J, Strunk T, Müller SC, Fechner G. Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage. Urologia Internationalis. 88: 390-4. PMID 22627127 DOI: 10.1159/000336874 |
0.027 |
|
| 2013 |
Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, et al. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks European Journal of Surgical Oncology. 39: 372-379. PMID 23465180 DOI: 10.1016/j.ejso.2013.02.009 |
0.027 |
|
| 2011 |
Dewald O, Duerr GD, Elhafi N, Bostani T, Ellinger J, Swieny L, Kolobara E, Welz A. Comparison of myocardial remodeling between cryoinfarction and reperfused infarction in mice Journal of Biomedicine and Biotechnology. 2011. PMID 21151617 DOI: 10.1155/2011/961298 |
0.027 |
|
| 2013 |
Li X, Han Q, Ellinger J, Zhang J, Wu Z. General total inter-carrier interference cancellation for OFDM high speed aerial vehicle communication Ieee International Conference On Communications. 4698-4702. DOI: 10.1109/ICC.2013.6655314 |
0.024 |
|
| 2011 |
May M, Bastian PJ, Burger M, Bolenz C, Trojan L, Herrmann E, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Otto W, Höfner T, Hohenfellner M, et al. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder. Bju International. 108: E278-83. PMID 21699644 DOI: 10.1111/j.1464-410X.2011.10189.x |
0.024 |
|
| 1983 |
Cole MB, Narine KR, Ellinger J. Morphological evidence of the shedding of chondrocytes from the articular surface in neonatal rats: Relationship to the interlacunar network Anatomical Record. 206: 439-446. PMID 6625202 |
0.023 |
|
| 1998 |
Ellinger J. The little engine that could and slowly will: a bureaucrat's view Frontiers of Health Services Management. 14: 27-30; discussion 41. PMID 10181815 |
0.023 |
|
| 1985 |
Greisler HP, Fareed J, Ellinger J. Inhibition of arterial regeneration by dacron Federation Proceedings. 44: No. 224. |
0.018 |
|
| 2012 |
Hauser S, Wulfken LM, Holdenrieder S, Moritz R, Ohlmann CH, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC, Ellinger J. Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma. Cancer Epidemiology. 36: 391-4. PMID 22542158 DOI: 10.1016/j.canep.2012.04.001 |
0.017 |
|
| 2007 |
Hauser S, Fisang C, Fechner F, Ellinger J, Haferkamp A, Müller SC. Ureterocystoplasty in the treatment of "low-compliance" bladder in children | Ureteraugmentation der blase bei kindern mit "low-compliance- blase" Urologe - Ausgabe A. 46: 1687-1690. PMID 18071774 DOI: 10.1007/s00120-007-1589-x |
0.016 |
|
| 2008 |
Hauser S, Fechner G, Gerhardt T, Klehr HU, Biermann K, Ellinger J, Müller SC. First report of an unexpected blind-ending duplication of the ureter as a rare pitfall in kidney transplantation. Transplant International : Official Journal of the European Society For Organ Transplantation. 21: 696-7. PMID 18435682 DOI: 10.1111/j.1432-2277.2008.00677.x |
0.014 |
|
| 2012 |
Shaikhibrahim Z, Lindstrot A, Ellinger J, Rogenhofer S, Buettner R, Perner S, Wernert N. The peripheral zone of the prostate is more prone to tumor development than the transitional zone: Is the ETS family the key? Molecular Medicine Reports. 5: 313-316. PMID 22038307 DOI: 10.3892/mmr.2011.647 |
0.014 |
|
| 2015 |
Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer. The Journal of Urology. 193: 331-7. PMID 25046619 DOI: 10.1016/j.juro.2014.07.010 |
0.012 |
|
| 2010 |
Hauser S, Fechner G, Ellinger J, Müller SC. [Urethral reconstructive surgery]. Der Urologe. Ausg. A. 49: 727-30. PMID 20503034 DOI: 10.1007/s00120-010-2311-y |
0.011 |
|
| 1934 |
Ellinger J. Über die mit that zusammengesetzten bindewörter im neueren englisch Anglia. 1934: 410-444. DOI: 10.1515/angl.1934.1934.58.410 |
0.01 |
|
| 2012 |
Ellinger J, Depoy R, Sanderson J, Huang K, Wu Z. Blind frequency offset estimation and intercarrier interference cancelation for FD-MC-CDMA systems in aerial vehicle communication Proceedings - Ieee Military Communications Conference Milcom. DOI: 10.1109/MILCOM.2012.6415840 |
0.01 |
|
| 2006 |
Ellinger J, Bastian PJ, Hauser S, Biermann K, Müller SC. Primitive neuroectodermal tumor: Rare, highly aggressive differential diagnosis in urologic malignancies Urology. 68: 257-262. PMID 16904430 DOI: 10.1016/j.urology.2006.02.037 |
0.01 |
|
| 2006 |
Ellinger J, Bastian PJ, Hauser S, Biermann K, Müller SC. Primitive neuroectodermal tumor of the kidney | Primitiver neuroektodermaler tumor der niere Urologe - Ausgabe A. 45: 735-738. PMID 16534648 DOI: 10.1007/s00120-006-1029-3 |
0.01 |
|
| 1999 |
Anderson P, Russell B, Ellinger J. An insider's view of three nursing specialties. Interview by Susan Trossman The American Nurse. 31: 1-2. PMID 2000137078 |
0.01 |
|
| 1977 |
Ellinger J. Adult orthodontics with removable appliances Journal (Anglo-Continental Dental Society). 12-18. PMID 281161 |
0.01 |
|
| 1933 |
Ellinger J. Substantivsätze mit oder ohne that in der neueren englischen literatur Anglia. 1933: 78-109. DOI: 10.1515/angl.1933.1933.57.78 |
0.01 |
|
| 1910 |
Ellinger J. Gerundium, infinitiv und that-satz als adverbale oder adnominale ergänzung Anglia. 1910: 480-522. DOI: 10.1515/angl.1910.1910.33.480 |
0.01 |
|
| Hide low-probability matches. |